Technology

Julie Frey, VP of product at Wolters Kluwer Health, discusses how the company's clinical decision support tool, which combines trusted evidence with generative AI, fits into clinical workflows and augments physicians' judgment.

The company will use the funds to drive commercial growth, broaden its employer and payer programs, and accelerate AI development.

The company's CEO, Tom Hale, told MobiHealthNews Oura will use the funds "for AI-driven innovation to redefine what digital health technology can do."

The package of bills aims to bolster protections for children using online chatbots, including prohibiting chatbots from representing themselves as healthcare professionals.

The company offers a patient recruitment platform for clinical trials.

Data from the study revealed that chronic exposure to cortisol disrupts neuronal network activity and damages long-term potentiation, simulating stress-related cognitive decline.

About 300 million prescription records were used to train the AI to reveal drug safety issues and opportunities for repurposing medicines.

The company offers computer vision technology that enables humanoids and robots to perceive the world in 3D similar to how humans use their eyes and depth perception.

The company will use the funds to expand its technology and operations across Medicaid, Medicare Advantage and ACA marketplace plans in the U.S.

The acquisition expands Datavant's capabilities to help insurance and legal professionals with AI-enabled tools for automated medical record review and predictive analytics.